Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$43.31 - $66.55 $5.3 Million - $8.15 Million
-122,426 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$43.33 - $51.72 $3.4 Million - $4.06 Million
-78,471 Reduced 39.06%
122,426 $5.78 Million
Q2 2020

Aug 13, 2020

BUY
$41.42 - $55.57 $144,017 - $193,216
3,477 Added 1.76%
200,897 $9.44 Million
Q1 2020

May 14, 2020

SELL
$36.67 - $61.04 $2.21 Million - $3.68 Million
-60,352 Reduced 23.41%
197,420 $8.82 Million
Q4 2019

Feb 14, 2020

BUY
$55.73 - $62.49 $2.46 Million - $2.76 Million
44,215 Added 20.7%
257,772 $15 Million
Q3 2019

Nov 14, 2019

BUY
$53.29 - $64.59 $1.16 Million - $1.41 Million
21,824 Added 11.38%
213,557 $12.8 Million
Q2 2019

Aug 14, 2019

SELL
$46.45 - $55.85 $1.42 Million - $1.71 Million
-30,617 Reduced 13.77%
191,733 $10.7 Million
Q1 2019

May 15, 2019

BUY
$42.97 - $57.33 $3.29 Million - $4.39 Million
76,571 Added 52.53%
222,350 $12.4 Million
Q4 2018

Feb 12, 2019

BUY
$42.62 - $64.51 $177,256 - $268,297
4,159 Added 2.94%
145,779 $6.58 Million
Q3 2018

Nov 13, 2018

BUY
$57.63 - $65.87 $4.81 Million - $5.5 Million
83,459 Added 143.5%
141,620 $9.33 Million
Q2 2018

Aug 07, 2018

SELL
$54.05 - $67.23 $7.18 Million - $8.93 Million
-132,839 Reduced 69.55%
58,161 $3.75 Million
Q1 2018

May 09, 2018

BUY
$46.55 - $57.38 $409,640 - $504,944
8,800 Added 4.83%
191,000 $10.6 Million
Q4 2017

Feb 14, 2018

BUY
$46.22 - $51.77 $247,277 - $276,969
5,350 Added 3.03%
182,200 $8.72 Million
Q3 2017

Nov 13, 2017

BUY
$47.8 - $53.63 $788,700 - $884,895
16,500 Added 10.29%
176,850 $8.93 Million
Q2 2017

Aug 14, 2017

BUY
N/A
160,350
160,350 $8.74 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.98B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.